Marcus Lind (M Lind)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 41

Top Topics

Glycemic Control

Clinical Practice

Silver Nanoparticles

Top Venues

Diabetes, obesity & metabolism

Journal of diabetes science and technology

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Nyström, Mikael Andersson Franko, Johnny Ludvigsson, Marcus Lind, Martina Persson
Overweight or obesity, weight variability and the risk of retinopathy in type 1 diabetes. Diabetes, obesity & metabolism (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Ramanjit Singh, Henrik Imberg, Shilan Seyed Ahmadi, Sara Hallström, Johan Jendle, Bengt-Olov Tengmark, Anna Folino, Ekström Marie, Marcus Lind
Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes. Journal of diabetes science and technology (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Linn Glynn, Marcus Lind, Tomas Andersson, Bjorn Eliasson, Robin Hofmann, Thomas Nyström
Trends in Survival After First Myocardial Infarction in People With Diabetes. Journal of the American Heart Association 13 (10) (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Linn Glynn, Marcus Lind, Tomas Andersson, Bjorn Eliasson, Robin Hofmann, Thomas Nyström
Trends in Survival After First Myocardial Infarction in People With Diabetes. Journal of the American Heart Association 13 (10) (2024)
Thomas Nyström, Mikael Andersson Franko, Johnny Ludvigsson, Marcus Lind, Martina Persson
Overweight or obesity, weight variability and the risk of retinopathy in type 1 diabetes. Diabetes, obesity & metabolism 26 (6) (2024)
Linn Glynn, Marcus Lind, Tomas Andersson, Bjorn Eliasson, Robin Hofmann, Thomas Nyström
Trends in Survival After First Myocardial Infarction in People With Diabetes. Journal of the American Heart Association 13 (10) (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Linn Glynn, Marcus Lind, Tomas Andersson, Bjorn Eliasson, Robin Hofmann, Thomas Nyström
Trends in Survival After First Myocardial Infarction in People With Diabetes. Journal of the American Heart Association (2024)
Ramanjit Singh, Henrik Imberg, Shilan Seyed Ahmadi, Sara Hallström, Johan Jendle, Bengt-Olov Tengmark, Anna Folino, Ekström Marie, Marcus Lind
Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes. Journal of diabetes science and technology (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia (2024)
Jon Edqvist, Christina Lundberg, Karin Andreasson, Lena Björck, Pigi Dikaiou, Johnny Ludvigsson, Marcus Lind, Martin Adiels, Annika Rosengren
Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden. Diabetes care 46 (3) (2023)
Jon Edqvist, Christina Lundberg, Karin Andreasson, Lena Björck, Pigi Dikaiou, Johnny Ludvigsson, Marcus Lind, Martin Adiels, Annika Rosengren
Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden. Diabetes care 46 (3) (2023)
Jon Edqvist, Christina Lundberg, Karin Andreasson, Lena Björck, Pigi Dikaiou, Johnny Ludvigsson, Marcus Lind, Martin Adiels, Annika Rosengren
Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden. Diabetes care (2023)
Anca Balintescu, Marcus Lind, Mikael Andersson Franko, Anders Oldner, Maria Cronhjort, Björn Eliasson, Christer Svensen, Johan Mårtensson
Glycemic control and sepsis risk in adults with type 1 diabetes. Diabetes, obesity & metabolism (2023)
Daniel Pylov, William H Polonsky, Henrik Imberg, Helen Holmer, Jarl Hellman, Magnus Wijkman, Jan Bolinder, Tim Heise, Sofia Dahlqvist, Thomas Nyström, Erik Schwarz, Irl B Hirsch, Marcus Lind
Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial. Journal of diabetes science and technology (2023)
Jon Edqvist, Christina Lundberg, Karin Andreasson, Lena Björck, Pigi Dikaiou, Johnny Ludvigsson, Marcus Lind, Martin Adiels, Annika Rosengren
Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden. Diabetes care 46 (3) (2023)
Jon Edqvist, Christina Lundberg, Karin Andreasson, Lena Björck, Pigi Dikaiou, Johnny Ludvigsson, Marcus Lind, Martin Adiels, Annika Rosengren
Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden. Diabetes care 46 (3) (2023)
David C Klonoff, Jing Wang, David Rodbard, Michael A Kohn, Chengdong Li, Dorian Liepmann, David C Klonoff, David T Ahn, Anne L Peters, Guillermo E Umpierrez, Jane Jefferie Seley, Nicole Y Xu, Kevin T Nguyen, Gregg D Simonson, Michael S D Agus, Mohammed E Al-Sofiani, Gustavo Armaiz-Pena, Timothy S Bailey, Ananda Basu, Tadej Battelino, Sewagegn Yeshiwas Bekele, Pierre Yves Benhamou, B Wayne Bequette, Thomas Blevins, Marc D Breton, Jessica R Castle, James Geoffrey Chase, Kong Y Chen, Pratik Choudhary, Mark A Clements, Kelly L Close, Curtiss B Cook, Thomas Danne, Francis J Doyle Iii, Andjela T Drincic, Kathleen M Dungan, Steven V Edelman, Niels Ejskjær, Juan C Espinoza, G Alexander Fleming, Gregory P Forlenza, Guido Freckmann, Rodolfo J Galindo, Ana Maria Gómez, Hanna A Gutow, Lutz Heinemann, Irl B Hirsch, Thanh Duc Hoang, Roman Hovorka, Johan H Jendle, Li-Nong Ji, Shashank R Joshi, Michael Joubert, Suneil K Koliwad, Rayhan A Lal, M Cecilia Lansang, Wei-An Andy Lee, Lalantha Leelarathna, Lawrence Alan Leiter, Marcus Lind, Michelle L Litchman, Julia Katharina Mader, Katherine M Mahoney, Boris Mankovsky, Umesh Masharani, Nestoras Nicolas Mathioudakis, Alexander Y Mayorov, Jordan Messler, Joshua D Miller, Viswanathan Mohan, James H Nichols, Kirsten Nørgaard, David Norman O'Neal, Francisco J Pasquel, Athena Philis-Tsimikas, Thomas R Pieber, Moshe Phillip, William H Polonsky, Pradipta R Ray, Gerry Rayman, Eun Jung Rhee, Steven J Russell, Viral N Shah, Jennifer L Sherr, Koji Sode, Elias K Spanakis, Deborah J Wake, Kayo Waki, Amisha Wallia, Melissa E Weinberg, Howard Wolpert, Eugene E Wright, Mihail Zilbermint, Boris P Kovatchev
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings. Journal of diabetes science and technology (2022)
Thomas Nyström, Erik Schwarz, Sofia Dahlqvist, Magnus Wijkman, Magnus Ekelund, Helen Holmer, Jan Bolinder, Jarl Hellman, Henrik Imberg, Irl B Hirsch, Marcus Lind
Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8). Journal of diabetes science and technology (2022)
Sara Hallström, Ann-Marie Svensson, Aldina Pivodic, Arndís Finna Ólafsdóttir, Magnus Löndahl, Hans Wedel, Marcus Lind
Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46,088 patients from the Swedish National Diabetes Registry. Diabetologia 64 (12) (2021)
Anca Balintescu, Marcus Lind, Mikael Andersson Franko, Anders Oldner, Maria Cronhjort, Ann-Marie Svensson, Bjorn Eliasson, Johan Mårtensson
Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2 Diabetes. Diabetes care (2021)
Marcus Lind, Henrik Imberg, Ruth L Coleman, Olle Nerman, Rury R Holman
Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88. Diabetes care (2021)
Johnny Ludvigsson, Zdenek Sumnik, Terezie Pelikanova, Lia Nattero Chavez, Elena Lundberg, Itxaso Rica, Maria Asuncion Martinez-Brocca, Marisol Ruiz de Adana, Jeanette Wahlberg, Anastasia Katsarou, Ragnar Hanas, Cristina Hernandez, Maria Clemente León, Ana Gómez-Gila, Marcus Lind, Marta Ferrer Lozano, Theo Sas, Ulf Samuelsson, Stepanka Pruhova, Fabricia Dietrich, Sara Puente Marin, Anders Nordlund, Ulf Hannelius, Rosaura Casas
Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial. Diabetes care 44 (7) (2021)
Mary Dena, Ann-Marie Svensson, Katarina Eeg Olofsson, Laura Young, Anders Carlson, Kellee Miller, Julia Grimsmann, Reinhard Welp, Julia K Mader, David M Maahs, Reinhard W Holl, Marcus Lind
Renal Complications and Duration of Diabetes: An International Comparison in Persons with Type 1 Diabetes. Diabetes therapy : research, treatment and education of diabetes and related disorders 12 (12) (2021)
Chantal Mathieu, Gottfried Rudofsky, Moshe Phillip, Eiichi Araki, Marcus Lind, Niki Arya, Fredrik Thorén, Markus F Scheerer, Nayyar Iqbal, Paresh Dandona
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial. Diabetes, obesity & metabolism 22 (9) (2020)
Marcus Lind, Arndís Finna Ólafsdóttir, Irl B Hirsch, Jan Bolinder, Sofia Dahlqvist, Aldina Pivodic, Jarl Hellman, Magnus Wijkman, Erik Schwarcz, Henrik Albrektsson, Tim Heise, William H Polonsky
Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI. Diabetes care 44 (1) (2020)
Moshe Phillip, Chantal Mathieu, Marcus Lind, Eiichi Araki, Paolo di Bartolo, Richard Bergenstal, Simon R Heller, Lars Hansen, Markus Florian Scheerer, Fredrik Thoren, Niki Arya, John Xu, Nayyar Iqbal, Paresh Dandona, null null
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies. Diabetes, obesity & metabolism 23 (2) (2020)
Arndís Finna Ólafsdóttir, Jan Bolinder, Tim Heise, William Polonsky, Magnus Ekelund, Magnus Wijkman, Aldina Pivodic, Elsa Ahlén, Erik Schwarcz, Thomas Nyström, Jarl Hellman, Irl B Hirsch, Marcus Lind
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5). Diabetes, obesity & metabolism 23 (2) (2020)
Tina Vilsbøll, Ella Ekholm, Eva Johnsson, Ricardo Garcia-Sanchez, Nalina Dronamraju, Serge A Jabbour, Marcus Lind
Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel-design, open-label, Phase 3 trial. Diabetes, obesity & metabolism 22 (6) (2020)
Shilan Seyed Ahmadi, Shilan Seyed Ahmadi, Aldina Pivodic, Arndís F Ólafsdóttir, Arndís Finna Ólafsdóttir, Irl B Hirsch, Irl B Hirsch, Magnus Ekelund, Tim Heise, William Polonsky, William H Polonsky, Erik Schwarcz, Marcus Lind
The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4). Diabetes care 43 (9) (2020)
Tina Vilsbøll, Ella Ekholm, Eva Johnsson, Nalina Dronamraju, Serge A Jabbour, Marcus Lind
Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial. Diabetes care 42 (8) (2019)
Chantal Mathieu, Paresh Dandona, Moshe Phillip, Tal Oron, Marcus Lind, Lars Hansen, Fredrik Thorén, John Xu, Anna Maria Langkilde, null null
Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2. Diabetes care 42 (6) (2019)
S S Ahmadi, K Filipsson, H Dimenäs, S S Isaksson, Henrik Imberg, S Sjöberg, Bo Ahrén, S Dahlqvist, T Gustafsson, J Tuomilehto, I B Hirsch, Marcus Lind
Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5). Obesity science & practice 5 (2) (2019)
Jon Edqvist, Araz Rawshani, Martin Adiels, Lena Björck, Marcus Lind, Ann-Marie Svensson, Sofia Gudbjörnsdottir, Naveed Sattar, Annika Rosengren
BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox. Diabetes care 42 (7) (2019)
Marcus Lind, Aldina Pivodic, Ann-Marie Svensson, Arndis F Ólafsdóttir, Hans Wedel, Johnny Ludvigsson
HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study. BMJ (Clinical research ed.) 366 (2019)
Mark L Evans, Antonio Ceriello, Thomas Danne, Christophe De Block, J Hans DeVries, Marcus Lind, Chantal Mathieu, Kirsten Nørgaard, Pr Eric Renard, Emma G Wilmot
Use of fast-acting insulin aspart in insulin pump therapy in clinical practice. Diabetes, obesity & metabolism 21 (9) (2019)
Jon Edqvist, Araz Rawshani, Martin Adiels, Lena Björck, Marcus Lind, Ann-Marie Svensson, Sofia Gudbjörnsdottir, Naveed Sattar, Annika Rosengren
BMI and Mortality in Patients With New-Onset Type 2 Diabetes: A Comparison With Age- and Sex-Matched Control Subjects From the General Population. Diabetes care 41 (3) (2018)
Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C Bain, Serge A Jabbour, Niki Arya, Lars Hansen, Fredrik Thorén, Anna Maria Langkilde, null null
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial. Diabetes care 41 (9) (2018)